Efficacy and safety of cysto-ventricular catheter implantation for space-occupying cysts arising from glioma and brain metastasis: a retrospective study.

Cysto-ventricular catheter Minimal-invasive Space-occupying cysts

Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
26 Jan 2024
Historique:
received: 03 10 2023
accepted: 06 12 2023
medline: 26 1 2024
pubmed: 26 1 2024
entrez: 26 1 2024
Statut: epublish

Résumé

Cysto-ventricular catheters (CVC) have emerged as promising treatment option for cystic craniopharyngioma and arachnoid cysts, but their effectiveness in treating cysts originating from glioma or brain metastasis (BM) remains limited. This study aimed to analyze the efficacy of CVC in patients with glioma and BM as well as procedure-associated morbidity. This single-center retrospective study included all patients treated with CVC placement for acquired space-occupying cysts deriving from previously treated glioma or BMs between 1/2010 and 12/2021. A total of 57 patients with a median age of 47 years (IQR 38-63) were identified. Focal neurological deficits were the predominant symptoms in 60% of patients (n = 34), followed by cephalgia in 14% (n = 8), and epileptic seizures in 21.1% (n = 12). Accurate CVC placement was achieved in all but one case requiring revision surgery due to malposition. Three months after CVC implantation, 70% of patients showed symptomatic improvement. Multivariate logistic regression analysis identified the development of space-occupying cysts later in the course of the disease (OR 1.014; p = 0.04) and a higher reduction of cyst-volume postoperatively (OR 1.055; p = 0.05) were significant predictors of postoperative symptomatic improvement following CVC placement. Local cyst recurrence was observed in three cases during follow-up MRI after an average time of 5 months (range 3-9 months). Further complications included secondary malresorptive hydrocephalus in three cases and meningeosis neoplastica in one patient. Stereotactic implantation of CVC is an efficient treatment option for patients suffering from symptomatic space-occupying cysts from BMs or glioma, independently from their CNS WHO grade. However, a vigilant approach is crucial regarding potential complications and treatment failures.

Sections du résumé

BACKGROUND BACKGROUND
Cysto-ventricular catheters (CVC) have emerged as promising treatment option for cystic craniopharyngioma and arachnoid cysts, but their effectiveness in treating cysts originating from glioma or brain metastasis (BM) remains limited. This study aimed to analyze the efficacy of CVC in patients with glioma and BM as well as procedure-associated morbidity.
METHODS METHODS
This single-center retrospective study included all patients treated with CVC placement for acquired space-occupying cysts deriving from previously treated glioma or BMs between 1/2010 and 12/2021.
RESULTS RESULTS
A total of 57 patients with a median age of 47 years (IQR 38-63) were identified. Focal neurological deficits were the predominant symptoms in 60% of patients (n = 34), followed by cephalgia in 14% (n = 8), and epileptic seizures in 21.1% (n = 12). Accurate CVC placement was achieved in all but one case requiring revision surgery due to malposition. Three months after CVC implantation, 70% of patients showed symptomatic improvement. Multivariate logistic regression analysis identified the development of space-occupying cysts later in the course of the disease (OR 1.014; p = 0.04) and a higher reduction of cyst-volume postoperatively (OR 1.055; p = 0.05) were significant predictors of postoperative symptomatic improvement following CVC placement. Local cyst recurrence was observed in three cases during follow-up MRI after an average time of 5 months (range 3-9 months). Further complications included secondary malresorptive hydrocephalus in three cases and meningeosis neoplastica in one patient.
CONCLUSIONS CONCLUSIONS
Stereotactic implantation of CVC is an efficient treatment option for patients suffering from symptomatic space-occupying cysts from BMs or glioma, independently from their CNS WHO grade. However, a vigilant approach is crucial regarding potential complications and treatment failures.

Identifiants

pubmed: 38277007
doi: 10.1007/s00701-024-05931-4
pii: 10.1007/s00701-024-05931-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

36

Informations de copyright

© 2024. The Author(s).

Références

Akmal S, Ginalis EE, Patel NV, Aiken R, Dicpinigaitis AJ, Hanft SJ (2021) Leptomeningeal disease in glioblastoma: endgame or opportunity? J Neurooncol 155:107–115. https://doi.org/10.1007/s11060-021-03864-x
doi: 10.1007/s11060-021-03864-x pubmed: 34623599
Alattar AA, Carroll K, Hirshman BR, Joshi RS, Sanghvi P, Chen CC (2018) Cystic formation after stereotactic radiosurgery of brain metastasis. World Neurosurg 114:e719–e728. https://doi.org/10.1016/j.wneu.2018.03.066
doi: 10.1016/j.wneu.2018.03.066 pubmed: 29551723
Beez T, Burgula S, Kamp M, Rapp M, Steiger HJ, Sabel M (2017) Space-occupying tumor bed cysts as a complication of modern treatment for high-grade glioma. World Neurosurg 104:509–515. https://doi.org/10.1016/j.wneu.2017.05.019
doi: 10.1016/j.wneu.2017.05.019 pubmed: 28512049
Castro BA, Imber BS, Chen R, McDermott MW, Aghi MK (2017) Ventriculoperitoneal shunting for glioblastoma: risk factors, indications, and efficacy. Neurosurgery 80:421–430. https://doi.org/10.1227/NEU.0000000000001263
doi: 10.1227/NEU.0000000000001263 pubmed: 27218235 pmcid: 6257011
Cheng H, Perez-Soler R (2018) Leptomeningeal metastases in non-small-cell lung cancer. Lancet Oncol 19:e43–e55. https://doi.org/10.1016/S1470-2045(17)30689-7
doi: 10.1016/S1470-2045(17)30689-7 pubmed: 29304362
Ciricillo SF, Cogen PH, Harsh GR, Edwards MS (1991) Intracranial arachnoid cysts in children. A comparison of the effects of fenestration and shunting. J Neurosurg 74:230–235. https://doi.org/10.3171/jns.1991.74.2.0230
doi: 10.3171/jns.1991.74.2.0230 pubmed: 1988593
Clark AJ, Lamborn KR, Butowski NA, Chang SM, Prados MD, Clarke JL, McDermott MW, Parsa AT, Berger MS, Aghi MK (2012) Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment. Neurosurgery 70:361–370. https://doi.org/10.1227/NEU.0b013e3182314f9d
doi: 10.1227/NEU.0b013e3182314f9d pubmed: 21841523
Dardis C, Milton K, Ashby L, Shapiro W (2014) Leptomeningeal metastases in high-grade adult glioma: development, diagnosis, management, and outcomes in a series of 34 patients. Front Neurol 5:220. https://doi.org/10.3389/fneur.2014.00220
doi: 10.3389/fneur.2014.00220 pubmed: 25404928 pmcid: 4217477
Franzoi MA, Hortobagyi GN (2019) Leptomeningeal carcinomatosis in patients with breast cancer. Crit Rev Oncol Hematol 135:85–94. https://doi.org/10.1016/j.critrevonc.2019.01.020
doi: 10.1016/j.critrevonc.2019.01.020 pubmed: 30819451
Ishikawa E, Yamamoto M, Saito A, Kujiraoka Y, Iijima T, Akutsu H, Matsumura A (2009) Delayed cyst formation after gamma knife radiosurgery for brain metastases. Neurosurgery 65:689–694. https://doi.org/10.1227/01.NEU.0000351771.46273.22 . (discussion 694-685)
doi: 10.1227/01.NEU.0000351771.46273.22 pubmed: 19834373
Katzendobler S, Do A, Weller J, Dorostkar MM, Albert NL, Forbrig R, Niyazi M, Egensperger R, Thon N, Tonn JC, Quach S (2022) Diagnostic yield and complication rate of stereotactic biopsies in precision medicine of gliomas. Front Neurol 13:822362. https://doi.org/10.3389/fneur.2022.822362
doi: 10.3389/fneur.2022.822362 pubmed: 35432168 pmcid: 9005817
Khan IS, Sonig A, Thakur JD, Nanda A (2013) Surgical management of intracranial arachnoid cysts: clinical and radiological outcome. Turk Neurosurg 23:138–143. https://doi.org/10.5137/1019-5149.JTN.5592-11.1
doi: 10.5137/1019-5149.JTN.5592-11.1 pubmed: 23546896
Kreth FW, Faist M, Rossner R, Birg W, Volk B, Ostertag CB (1997) The risk of interstitial radiotherapy of low-grade gliomas. Radiother Oncol 43:253–260. https://doi.org/10.1016/s0167-8140(97)01948-8
doi: 10.1016/s0167-8140(97)01948-8 pubmed: 9215784
Lee EJ, Ra YS (2012) Clinical and neuroimaging outcomes of surgically treated intracranial cysts in 110 children. J Korean Neurosurg Soc 52:325–333. https://doi.org/10.3340/jkns.2012.52.4.325
doi: 10.3340/jkns.2012.52.4.325 pubmed: 23133720 pmcid: 3488640
Lenski M, Biczok A, Tonn JC, Kreth FW (2019) Stereotactic internal shunt placement in congenital intracranial cysts. World Neurosurg 123:e670–e677. https://doi.org/10.1016/j.wneu.2018.11.250
doi: 10.1016/j.wneu.2018.11.250 pubmed: 30576829
Meissner AK, Dreher L, Junger ST, Visser-Vandewalle V, Ruge MI, Ruess D (2021) Frame-based stereotactic implantation of cystoventricular shunts for treating acquired intracerebral cysts. J Neurosurg 1–8. https://doi.org/10.3171/2021.7.JNS211180
Montano N, D’Alessandris QG, Bianchi F, Lauretti L, Doglietto F, Fernandez E, Maira G, Pallini R (2011) Communicating hydrocephalus following surgery and adjuvant radiochemotherapy for glioblastoma. J Neurosurg 115:1126–1130. https://doi.org/10.3171/2011.8.JNS11738
doi: 10.3171/2011.8.JNS11738 pubmed: 21905801
Mustansir F, Bashir S, Darbar A (2018) Management of arachnoid cysts: a comprehensive review. Cureus 10:e2458. https://doi.org/10.7759/cureus.2458
doi: 10.7759/cureus.2458 pubmed: 29888162 pmcid: 5991924
Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842–1850. https://doi.org/10.1001/jama.2013.280319
doi: 10.1001/jama.2013.280319 pubmed: 24193082
Poisson M, Philippon J, van Effenterre R, Racadot J, Sichez JP (1977) Cerebral pseudocysts following chemotherapy of glioblastomas. Acta Neurochir (Wien) 39:143–149. https://doi.org/10.1007/BF01406723
doi: 10.1007/BF01406723 pubmed: 203172
Rachinger W, Oehlschlaegel F, Kunz M, Fuetsch M, Schichor C, Thurau S, Schopohl J, Seelos K, Tonn JC, Kreth FW (2017) Cystic craniopharyngiomas: microsurgical or stereotactic treatment? Neurosurgery 80:733–743. https://doi.org/10.1227/NEU.0000000000001408
doi: 10.1227/NEU.0000000000001408 pubmed: 27973392
Ruge MI, Kickingereder P, Grau S, Dorn F, Galldiks N, Treuer H, Sturm V (2013) Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region. Neuro Oncol 15:1721–1731. https://doi.org/10.1093/neuonc/not126
doi: 10.1093/neuonc/not126 pubmed: 24046261 pmcid: 3829594
Ruge MI, Kickingereder P, Simon T, Treuer H, Sturm V (2012) Stereotactic iodine-125 brachytherapy for treatment of inoperable focal brainstem gliomas of WHO grades I and II: feasibility and long-term outcome. J Neurooncol 109:273–283. https://doi.org/10.1007/s11060-012-0889-1
doi: 10.1007/s11060-012-0889-1 pubmed: 22580799
Ruge MI, Simon T, Suchorska B, Lehrke R, Hamisch C, Koerber F, Maarouf M, Treuer H, Berthold F, Sturm V, Voges J (2011) Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome. J Clin Oncol 29:4151–4159. https://doi.org/10.1200/JCO.2011.37.3381
doi: 10.1200/JCO.2011.37.3381 pubmed: 21969508
Soffietti R, Ruda R, Mutani R (2002) Management of brain metastases. J Neurol 249:1357–1369. https://doi.org/10.1007/s00415-002-0870-6
doi: 10.1007/s00415-002-0870-6 pubmed: 12382150
Steiert C, Grauvogel J, Roelz R, Demerath T, Schnell D, Beck J, Coenen VA, Reinacher PC (2021) Stereotactic cysto-ventricular catheters in craniopharyngiomas: an effective minimally invasive method to improve visual impairment and achieve long-term cyst volume reduction. Neurosurg Rev 44:3411–3420. https://doi.org/10.1007/s10143-021-01510-8
doi: 10.1007/s10143-021-01510-8 pubmed: 33674982 pmcid: 8592958
Stephens S, Tollesson G, Robertson T, Campbell R (2019) Diffuse midline glioma metastasis to the peritoneal cavity via ventriculo-peritoneal shunt: Case report and review of literature. J Clin Neurosci 67:288–293. https://doi.org/10.1016/j.jocn.2019.06.043
doi: 10.1016/j.jocn.2019.06.043 pubmed: 31266714
Stoecklein VM, Kellert L, Patzig M, Kupper C, Giese A, Ruf V, Weller J, Kreth FW, Schoberl F (2021) Extended stereotactic brain biopsy in suspected primary central nervous system angiitis: good diagnostic accuracy and high safety. J Neurol 268:367–376. https://doi.org/10.1007/s00415-020-10157-2
doi: 10.1007/s00415-020-10157-2 pubmed: 32813052
Talamonti G, D’Aliberti G, Picano M, Debernardi A, Collice M (2011) Intracranial cysts containing cerebrospinal fluid-like fluid: results of endoscopic neurosurgery in a series of 64 consecutive cases. Neurosurgery 68:788–803. https://doi.org/10.1227/NEU.0b013e318207ac91 . (discussion 803)
doi: 10.1227/NEU.0b013e318207ac91 pubmed: 21311305
Yamamoto M, Kawabe T, Higuchi Y, Sato Y, Nariai T, Barfod BE, Kasuya H, Urakawa Y (2013) Delayed complications in patients surviving at least 3 years after stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 85:53–60. https://doi.org/10.1016/j.ijrobp.2012.04.018
doi: 10.1016/j.ijrobp.2012.04.018 pubmed: 22652110

Auteurs

Sebastian Niedermeyer (S)

Department of Neurosurgery, LMU Hospital, Ludwig-Maximilian-University Munich, Marchioninistrasse 15, 81377, Munich, Germany. sebastian.niedermeyer@med.uni-muenchen.de.

Nicole A Terpolilli (NA)

Department of Neurosurgery, LMU Hospital, Ludwig-Maximilian-University Munich, Marchioninistrasse 15, 81377, Munich, Germany.

Pia Nerlinger (P)

Department of Neurosurgery, LMU Hospital, Ludwig-Maximilian-University Munich, Marchioninistrasse 15, 81377, Munich, Germany.

Jonathan Weller (J)

Department of Neurosurgery, LMU Hospital, Ludwig-Maximilian-University Munich, Marchioninistrasse 15, 81377, Munich, Germany.

Michael Schmutzer-Sondergeld (M)

Department of Neurosurgery, LMU Hospital, Ludwig-Maximilian-University Munich, Marchioninistrasse 15, 81377, Munich, Germany.

Stefanie Quach (S)

Department of Neurosurgery, LMU Hospital, Ludwig-Maximilian-University Munich, Marchioninistrasse 15, 81377, Munich, Germany.

Niklas Thon (N)

Department of Neurosurgery, LMU Hospital, Ludwig-Maximilian-University Munich, Marchioninistrasse 15, 81377, Munich, Germany.

Classifications MeSH